Wynnewood, PA (PRWEB) October 18, 2010
Olfactory Biosciences Corp (OTC Pink Sheets: OLFC) announced today that NOXO Study Boost and NOXO Memory Enhancer are now available as nasal inhalers and balms. These natural, non-invasive, safe and non-drug breakthrough products are significant alternatives for amphetamine (Adderall) non-prescription users.
The new NOXO products are the resulting combination of NOBEL Prize Winning science (Nobel Prize in Medicine of 2004, Richard Axel, Linda B. Buck) and NOXO’s Advanced Olfaction Science. This means there is now a great, natural way to enhance memory, alertness and concentration.
A University of Cincinnati study showed NOXO Study and Memory product ingredient’s ability to improve concentration and mental sharpness. It was also found that when inhaling specific phytochemicals and phytonutrients present in NOXO, there was an increase in mental accuracy, improvement in concentration and mental performance, of college students by 28 percent. (study by Dr. William N. Dember)
Problem: '60-MINUTES' television hour, where the subject was the current college use of the non prescription use of amphetamine drug Adderall, Prof. Alan DeSantis estimated its use at university fraternities and sororities at 80%. Professor Alan DeSantis (University of Kentucky communications professor) also found that 43 percent of students felt Adderall use meant the difference between a C and an A.
Beyond the health and legal consequences of the Class II controlled drug is the ethical debate surrounding Adderall’s devaluation of the college experience and the lack of knowledge of the drug’s short and long-term effects including schizophrenia.
One study with the ingredients in NOXO Study Boost™ and NOXO Memory Enhancer™ showed that participants’ performance on a cognitive assessment battery of tests showed enhanced memory performance as compared to the control group. The participants in this study were given math computations before and after receiving NOXO ingredients. After inhalation, those in the group did the math problems more quickly and more accurately.
NOXO products contain special proprietary formulations of phytonutrients and phytochemicals taken from plants, flowers, roots and seeds.
About Olfactory Biosciences Corp
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples. The company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from all natural ingredients. Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp’s unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market, creating a growth rate ten times higher than most in the this growing category. Consumers concerned about their health are looking for alternatives to replace conventional, over-the-counter consumer medical products. We provide natural wellness products that are both effective and affordable.
Investor & Media Relations:
Safe Harbor for Public Companies
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Olfactory Biosciences Corp., "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Olfactory Biosciences Corp. website as they become available.
Olfactory Biosciences Corp
333 E. Lancaster Ave.
Wynnewood, PA 19096